1 results for "Anouk Schrantee"

Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate

Anouk Schrantee; Jordi L. Tremoleda; Marzena Wylezinska-Arridge et al.

PLOS ONE, Vol. 12 No. 2 · 2017 · English · PLOS Scopus

Dexamphetamine (AMPH) is a psychostimulant drug that is used both recreationally and as medication for attention deficit hyperactivity disorder. Preclinical studies have demonstrated that repeated exposure to AMPH can induce damage to nerve terminals of dopamine (DA) neurons. We here assessed the…